期刊文献+

MicroRNA在人胰腺癌中表达谱的初步研究 被引量:8

Preliminary study of microRNA expression profiles in human pancreatic cancer
原文传递
导出
摘要 目的:探讨微小RNA(miRNA)在人胰腺癌中的表达谱,为进一步研究miRNA在胰腺癌发生发展中的分子机制奠定基础。方法:利用miRNA芯片技术比较胰腺癌组织和癌旁正常胰腺组织的miRNA表达差异;挑选其中两个差异表达的miRNA运用荧光定量实时聚合酶链反应(qRT-PCR)验证。结果:与正常胰腺组织相比,胰腺癌组织中表达上调超过1.5倍的miRNA有15个,表达下调超过1.5倍的miRNA有11个;qRT-PCR检测8例胰腺癌组织和相应癌旁正常胰腺组织中miR-10b的相对表达量分别为0.0743±0.0222和0.0287±0.0129;miR-21相对表达量分别为0.3062±0.1117和0.0240±0.0137(均P<0.05),与miRNA芯片结果相符合。结论:miRNA芯片筛选出的26种差异表达的miRNA可能与胰腺癌的发生发展相关,其各自在胰腺癌中的作用值得进一步研究。 Objective: To investigate the microRNAs(miRNAs) expression profiles in human pancreatic cancer,so as to provide a basis for further exploring the role of miRNAs in the molecular mechanism that leads to the occurrence and development of pancreatic cancer. Methods: The differentially expressed miRNAs between the pancreatic cancer tissue and adjacent normal pancreatic tissue were analyzed by microRNA array,and then two of the differentially expressed miRNA were selected to perform quantitative real time PCR(qRT-PCR) assay,so as to validate the microRNA array results. Results: Compared with the normal pancreatic tissues,15 miRNAs were more than 1.5-fold up-regulated,and 11 miRNAs were more than 1.5-fold down-regulated in pancreatic cancer tissues.The values of relative quantification(RQ) of miR-10b and miR-21 in pancreatic cancer tissues and their adjacent normal tissues from 8 cases detected by qRT-PCR were 0.0743±0.0222 vs.0.0287±0.0129,and 0.3062±0.1117 vs.0.0240±0.0137,respectively(both P0.05),and these were consistent with the microRNA array results. Conclusion: The 26 differentially expressed miRNAs screened by microRNA array may contribute to the occurrence and development of pancreatic cancer,and their respective roles in this disease are worthy of further investigation.
出处 《中国普通外科杂志》 CAS CSCD 北大核心 2012年第3期312-316,共5页 China Journal of General Surgery
基金 福建省自然科学基金资助项目(2009J01134)
关键词 胰腺肿瘤 微小RNA 微阵列分析 聚合酶链反应 Pancreatic Neoplasms microRNA Microarray Analysis Polymerase Chain Reaction
  • 相关文献

参考文献19

  • 1Bentwich I, Avniel A, Karov Y, et al. Identification of hundreds of conserved and nonconserved human microRNAs[J]. Natl Genet 2005, 37(7):766-770.
  • 2Carthew RW. Gene regulation by microRNAs[J]. Curr Opin Gene Dev, 2006, 16(2): 203-208.
  • 3Ambros V. The functions of animal microRNAs[J]. Nature, 2004, 431 (7006):350-355.
  • 4Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function[J]. Cell, 2004, 116(2): 251-297.
  • 5Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers[J]. Nature, 2005, 435(7043):834-838.
  • 6Volinia S, Calin GA, Liu CG, et al. A microRNA expression signature of human solid tumors defines cancer gene targets[J]. Proc Natl Acad Sci U S A, 2006, 103(7):2257-2261.
  • 7Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J]. Cancer Cell, 2006, 9(3): 189-198.
  • 8Iorio MV, Ferraein M, Liu CG, et al. MieroRNA gene expression deregulation in human breast cancer[J]. Cancer Res, 2005, 65(16):7065-7070.
  • 9包俊杰,吴诚义.MicroRNA在恶性肿瘤发生发展中所起作用的研究现状[J].中国普通外科杂志,2009,18(12):1301-1303. 被引量:3
  • 10Roldo C, Missiaglia E, Hagan JP, et al. MicroRNA expression abnormalities in pancreatic endocrine and acinar tumors are associated with distinctive pathologic features and clinical behavior[J]. J Clin Oncol, 2006, 24(29):4677-4684.

二级参考文献28

  • 1Sini RA, Trink B, Nissan A. The role of microRNA in tumorigenesis: key players or innocent bystanders [ J ]. J Surg Oncol, 2009, 99 (3):135 -136.
  • 2Griffiths - Jones S, Saini HK, van Dongen S, et al. miRBase: tools for microRNA genomics [ J ] . Nucleic Acids Res, 2008, 36: 154 - 158.
  • 3Bartel DP. MicroRNAs: genomies, biogenesis, mechanism, and function [J]. Cell Press,2004, 116 (2) :281 -297.
  • 4Hutvagner G, Zamore PD. A microRNA in a multiple-turnoverRNAi en zyme complex [ J ]. Science 2002, 297 ( 5589 ) : 2056 - 2060.
  • 5Hornstein E, Mansfield JH, Yekta S, et al. The microRNAmiR-196 acts upstream of Hoxb8 and Shh in limb development [ J ]. Nature, 2005, 438 ( 7068 ) : 671 - 674.
  • 6Aukerman M J, Sakai H. Regulation of flowering time and floral organ identity by a MicroRNA and its APETALA2-like target genes [ J ]. Plant Cell, 2003, 15 ( 11 ) : 2730-2741.
  • 7Sen GL, Blau HM. Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies [J]. Nat Cell Biol, 2005, 7(6) : 633 -636.
  • 8Hayashita Y, Osada H, Tatematsu Y, et al. A polycistronicmicroRNA cluster, miR-17-92, is overexpressed in humanlung cancers and enhances cell proliferation [ J ]. Cancer Res, 2005, 65 (21) : 9628 -9632.
  • 9Cimmino A, Calin GA, Fabbri M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2 [ J ] . Proc Natl Acad Sci USA, 2005, 102(39) : 13944-13949.
  • 10Medina PP, Slack FJ. microRNAs and cancer, an overview [ J ]. Cell Cycle, 2008, 7 (16) : 2485 - 2492.

共引文献2

同被引文献91

  • 1潘博,郭俊超,廖泉,赵玉沛.吉西他滨与胰腺癌化疗耐药[J].中国普外基础与临床杂志,2005,12(5):530-532. 被引量:16
  • 2Yang H,Kong W,He L,et al. MicroRNA expression profiling in hu-man ovarian cancer : miR-214 induces cell survival and cisplatin re-sistance by targeting PTEN[ J]. Cancer Res,2008,68(2) ;425-433.
  • 3Calin GA,Croce CM. MicroRNA signatures in human cancers[J]. NatRev Cancer,2006,6( 11) :857-866.
  • 4Bloomston M, Frankel WL, Petrocca F, et al. MicroRNA expressionpatterns to differentiate pancreatic adenocarcinoma from normal pan-creas and chronic pancreatitis [ J ]. JAMA,2007 , 297 ( 17 ) ; 1901 -1908.
  • 5Ma K,He Y,Zhang H,et al. DNA methylation-regulated miR-193a-3pdictates resistance of hepatocellular carcinoma to 5-fluorouracil via re-pression of SRSF2 expression[ I]. J Biol Chem,2012,287 ( 8) :5639-5649.
  • 6Ladeiro Y,Couehy G,Balabaud C,et al. MicroRNA profiling in hepa-tocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations[ J]. Hepatobiliary,2008,47 (15 ):1955-1963.
  • 7Tian YY,Luo AP,Cai YR,et al. MicroRNA-lOb promotes migrationand invasion through KLF4 in human esophageal cancer cell lines[J]. J Bio Chem, 2010,285(11) :7986-7994.
  • 8Ma L,Teruya-Feldstein J,Weinberg RA. Tumour invasion and metas-tasis initiated by microRNA-lOb in breast cancer[ J ]. Nature, 2007,449:682-688.
  • 9Rosenthal DT,Iyer H,Escudero S,et al. p38y promotes breast cancercell motility and metastasis through regulation of RhoC GTPase, cy-toskeletal architecture,and a novel leading edge behavior[ J ]. CancerRes,2011,71(20) :6338-6349.
  • 10Ueno K, Hirata H, Majid S, et al. Tumor suppressor microRNA-493decreases cell motility and migration ability in human bladder cancercells by downregulating RhoC and FZD4 [ J ] . Mol Cancer Ther,2012,11(1) :244-253.

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部